From: The potential therapeutic effect of platelet-rich plasma in the treatment of post-COVID-19 parosmia
Group | Pretreatment VAS Mean ± SD | Post-treatment VAS Mean ± SD | Wilcoxon sign rank test | p-value |
---|---|---|---|---|
Case group (30 patients) | 9.13 ± 0.73 | 3.33 ± 3.29 | z = − 4.3724 | p < 0.00001 |
Control group (30 patients) | 9.27 ± 0.78 | 7.43 ± 2.84 | z = − 3.0594 | 0.002 |